An in vitro model of meningioma constructed by 3D coaxial bioprinting

Meningioma, a type of brain tumor, has a high incidence rate and requires a comprehensive treatment approach due to its invasive nature and varying malignancy. In vitro models for studying the molecular mechanisms of malignant meningiomas and drug screening are urgently needed. However, two-dimensional (2D) culture of meningioma cells has limitations and challenges. Three-dimensional (3D) printing technology can provide a more realistic in vitro research platform for tumor research. In this study, 3D coaxial bioprinting was used to fabricate an in vitro 3D model of meningioma that faithfully recapitulates the biological characteristics and microenvironment of this malignancy. The bioprinted construct features a fibrous core-shell structure that allows cell clustering and fusion into cell fibers, ultimately forming a complex 3D structure resembling meningioma. Our findings suggest that the 3D model of meningioma generated by coaxial bioprinting closely resembles the in vivo morphology and growth pattern. Compared with 2D culture, 3D culture conditions better simulated the tumor microenvironment and exhibited higher invasiveness and tumorigenicity. Comparative analysis of biomarker expression further demonstrated that 3D culture provides a more accurate reflection of the biological characteristics of tumors. Our research affirms that microtissue models produced by 3D coaxial bioprinting can replicate the in vivo environment of cancer cells, producing survival conditions that are nearly realistic and more conducive to the restoration of cancer cell traits in vitro.
- Cao J, Yan W, Li G, Zhan Z, Hong X, Yan H. Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018. Int J Cancer. 2022;151(11):1874-1888. doi: 10.1002/ijc.34198
- Dolecek TA, Dressler EVM, Thakkar JP, Liu M, Al-Qaisi A, Villano JL. Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act. Cancer. 2015;121(14):2400-2410. doi: 10.1002/cncr.29379
- Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: A review. JAMA. 2023;329(7):574-587. doi: 10.1001/jama.2023.0023
- Di Nunno V, Giannini C, Asioli S, et al. Diagnostic and therapeutic strategy in anaplastic (malignant) meningioma, CNS WHO Grade 3. Cancers. 2022;14(19):4689. doi: 10.3390/cancers14194689
- Shahbandi A, Shah DS, Hadley CC, Patel AJ. The role of pharmacotherapy in treatment of meningioma: A systematic review. Cancers. 2023;15(2):483. doi: 10.3390/cancers15020483
- Mei Y, Bi WL, Greenwald NF, et al. Genomic profile of human meningioma cell lines. PLoS One. 2017;12(5):e0178322. doi: 10.1371/journal.pone.0178322
- Kim E, Kim M, So K, Park YS, Woo CG, Hyun S-H. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors. Cancer Cell Int. 2020;20:345. doi: doi.org/10.1186/s12935-020-01438-x
- Magill ST, Vasudevan HN, Seo K, et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat Commun. 2020;11(1):4803. doi: 10.1038/s41467-020-18582-7
- Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: Tumor application, advantages, and disadvantages. Int J Mol Sci. 2021;22(22):12200. doi: 10.3390/ijms222212200
- Jubelin C, Muñoz-Garcia J, Griscom L, et al. Three-dimensional in vitro culture models in oncology research. Cell Biosci. 2022;12(1):155. doi: 10.1186/s13578-022-00887-3
- Fontana F, Marzagalli M, Sommariva M, Gagliano N, Limonta P. In vitro 3D cultures to model the tumor microenvironment. Cancers. 2021;13(12). doi: 10.3390/cancers13122970
- Kang Y, Datta P, Shanmughapriya S, Ozbolat IT. 3D bioprinting of tumor models for cancer research. ACS Appl Bio Mater. 2020;3(9):5552-5573. doi: 10.1021/acsabm.0c00791
- Nath S, Devi GR. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther. 2016;163:94-108. doi: 10.1016/j.pharmthera.2016.03.013
- Samadian H, Jafari S, Sepand MR, et al. 3D bioprinting technology to mimic the tumor microenvironment: Tumor-on-a-chip concept. Mater Today Adv. 2021;12:100160. doi: 10.1016/j.mtadv.2021.100160
- Han S, Kim S, Chen Z, et al. 3D bioprinted vascularized tumour for drug testing. Int J Mol Sci. 2020;21(8). doi: 10.3390/ijms21082993
- Hwang DG, Choi YM, Jang J. 3D bioprinting-based vascularized tissue models mimicking tissue-specific architecture and pathophysiology for in vitro studies. Front Bioeng Biotechnol. 2021;9:685507. doi: 10.3389/fbioe.2021.685507
- Zhu X, Li H, Huang L, Zhang M, Fan W, Cui L. 3D printing promotes the development of drugs. Biomed Pharmacother. 2020;131:110644. doi: 10.1016/j.biopha.2020.110644
- Gao G, Ahn M, Cho WW, Kim B-S, Dong-Cho W. 3D printing of pharmaceutical application: Drug screening and drug delivery. Pharmaceutics. 2021;13(9):1373. doi: 10.3390/pharmaceutics13091373
- Chen J, Zhou D, Nie Z, et al. A scalable coaxial bioprinting technology for mesenchymal stem cell microfiber fabrication and high extracellular vesicle yield. Biofabrication. 2021;14(1):015012. doi: 10.1088/1758-5090/ac3b90
- Nasrallah MP, Aldape KD. Molecular classification and grading of meningioma. J Neurooncol. 2023;161(2):373-381. doi: 10.1007/s11060-022-04228-9
- Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3):319. doi: 10.3390/biomedicines9030319
- Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci. 2020;7:33. doi: 10.3389/fmolb.2020.00033
- Jain P, Kathuria H, Dubey N. Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models. Biomaterials. 2022;287:121639. doi: 10.1016/j.biomaterials. 2022.121639
- Persaud A, Maus A, Strait L, Zhu D. 3D Bioprinting with live cells. Eng Regen. 2022;3(3):292-309. doi: 10.1016/j.engreg.2022.07.002
- Zhang Y, Yu Y, Chen H, Ozbolat IT. Characterization of printable cellular micro-fluidic channels for tissue engineering. Biofabrication. 2013;5(2):025004. doi: 10.1088/1758-5082/5/2/025004
- Hanselmann RG, Welter C. Origin of cancer: Cell work is the key to understanding cancer initiation and progression. Front Cell Dev Biol. 2022;10:787995. doi: 10.3389/fcell.2022.787995
- Zhang Y, Chen H, Long X, Xu T. Three-dimensional-engineered bioprinted in vitro human neural stem cell self-assembling culture model constructs of Alzheimer’s disease. Bioact Mater. 2022;11:192-205. doi: 10.1016/j.bioactmat.2021.09.023
- Colombo E, Cattaneo MG. Multicellular 3D models to study tumour-stroma interactions. Int J Mol Sci. 2021; 22(4). doi: 10.3390/ijms22041633
- Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 2008;3(9-10):1172-1184. doi: 10.1002/biot.200700228
- Kapałczyńska M, Kolenda T, Przybyła W, et al. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. AMS. 2018;14(4):910-919. doi: 10.5114/aoms.2016.63743
- Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J Neurooncol. 2010;99(3): 379-391. doi: 10.1007/s11060-010-0342-2
- Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839-845. doi: 10.1038/nrm2236
- Shamir ER, Ewald AJ. Three-dimensional organotypic culture: Experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014;15(10):647-664. doi: 10.1038/nrm3873
- Wang X, Li X, Ding J, et al. 3D bioprinted glioma microenvironment for glioma vascularization. J Biomed Mater Res Part A. 2021;109(6):915-925. doi: 10.1002/jbm.a.37082
- Weigelt B, Ghajar CM, Bissell MJ. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev. 2014;69-70:42-51. doi: 10.1016/j.addr.2014.01.001
- Zhao Y, Zhang B, Ma Y, et al. Colorectal cancer patient-derived 2D and 3D models efficiently recapitulate inter- and intratumoral heterogeneity. Adv Sci. 2022;9(22):e2201539. doi: 10.1002/advs.202201539
- Lazzari G, Nicolas V, Matsusaki M, Akashi M, Couvreur P, Mura S. Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity. Acta Biomater. 2018;78:296-307. doi: 10.1016/j.actbio.2018.08.008